News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Stejbach Mark
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/19/2021 |
4
| Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Disposed/sold 12,631 shares
@ $8.5, valued at
$107.4k
Disposed/sold 25,000 options to buy
@ $15.87, valued at
$396.8k
Disposed/sold 12,500 options to buy
@ $20.16, valued at
$252k
Disposed/sold 12,500 options to buy
@ $28.14, valued at
$351.8k
Disposed/sold 12,500 options to buy
@ $11.74, valued at
$146.8k
Disposed/sold 7,000 options to buy
@ $11.88, valued at
$83.2k
Disposed/sold 7,000 options to buy
@ $9.22, valued at
$64.5k
|
|
| 06/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 4,500 shares
@ $0
Granted 7,000 options to buy
@ $11.88, valued at
$83.2k
|
|
| 05/27/2020 |
4
| Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Bought 2,051 shares
@ $9.75, valued at
$20k
|
|
| 06/21/2019 |
4
| Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 12,500 options to buy
@ $11.74, valued at
$146.8k
|
|
| 06/21/2018 |
4
| Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 12,500 options to buy
@ $28.14, valued at
$351.8k
|
|
| 03/05/2018 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 2,334 shares
@ $57.41, valued at
$134k
Paid exercise price by delivering 1,251 shares
@ $60.05, valued at
$75.1k
Exercised 5,250 options to buy
@ $0
Exercised 2,813 options to buy
@ $0 |
|
| 02/28/2018 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Gifted 1,000 shares
@ $0
Paid exercise price by delivering 1,167 shares
@ $58.12, valued at
$67.8k
Exercised 2,625 options to buy
@ $0 |
|
| 02/21/2018 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 10,880 shares
@ $70.5048, valued at
$767.1k
Paid exercise price by delivering 884 shares
@ $67.26, valued at
$59.5k
Exercised 10,880 options to buy
@ $17.3, valued at
$188.2k
Granted 54,500 options to buy
@ $67.26, valued at
$3.7M
Granted 13,500 options to buy
@ $0
Exercised 3,000 options to buy
@ $0 |
|
| 07/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 10,000 shares
@ $60.3352, valued at
$603.4k
Exercised 10,000 options to buy
@ $17.3, valued at
$173k
|
|
| 05/30/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Exercised 2,500 options to buy
@ $0 |
|
| 03/06/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 03/02/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 02/27/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 02/21/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 01/10/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 01/06/2017 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 11/14/2016 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 10/06/2016 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc. |
| 09/14/2016 |
4
| Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc|
Txns:
| Granted 25,000 options to buy
@ $15.87, valued at
$396.8k
|
|
| 09/14/2016 |
3
| Stejbach Mark (Director) has filed a Form 3 on Flexion Therapeutics Inc |
| 06/01/2016 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Exercised 2,500 options to buy
@ $0 |
|
| 03/04/2016 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Exercised 2,813 options to buy
@ $0 |
|
| 03/01/2016 |
4
| Stejbach Mark (SVP/Chief Comm Off, Alks Inc) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 852 shares
@ $33.61, valued at
$28.6k
Exercised 2,625 options to buy
@ $0
Granted 85,000 options to buy
@ $32.27, valued at
$2.7M
Granted 21,000 options to buy
@ $0 |
|
| 12/28/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 10,000 shares
@ $80.2392, valued at
$802.4k
Exercised 10,000 options to buy
@ $17.3, valued at
$173k
|
|
| 12/02/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 15,200 shares
@ $71.9943, valued at
$1.1M
Sold 2,300 shares
@ $73.0891, valued at
$168.1k
Sold 500 shares
@ $73.582, valued at
$36.8k
Exercised 18,000 options to buy
@ $17.3, valued at
$311.4k
|
|
| 11/12/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Gifted 400 shares
@ $0 |
|
| 11/04/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Sold 15,670 shares
@ $71.9993, valued at
$1.1M
Sold 2,330 shares
@ $72.5062, valued at
$168.9k
Exercised 18,000 options to buy
@ $17.3, valued at
$311.4k
|
|
| 10/07/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 5,000 shares
@ $0
Paid exercise price by delivering 1,676 shares
@ $59.77, valued at
$100.2k
Granted 5,000 options to buy
@ $0 |
|
| 05/29/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 813 shares
@ $59.92, valued at
$48.7k
Exercised 2,500 options to buy
@ $0 |
|
| 04/17/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 1,591 shares
@ $62.83, valued at
$100k
Exercised 5,780 options to buy
@ $17.3, valued at
$100k
|
|
| 03/05/2015 |
4
| Stejbach Mark (Chief Commercial Officer) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 914 shares
@ $72.8, valued at
$66.5k
Exercised 2,812 options to buy
@ $0 |
|
|
|
|